Furthermore, cancer cells can release TGF-β or IL-6 in the TME to activate cancer-associated fibroblasts (CAFs), that in turn can contribute to the suppression of NK cells cytotoxicity and cytokine production (30). Here, TGFB1 is linked to cancer.